Verix Health, formerly know as Greppo Technologies, a Santa Clara, CA-based a developer of a portfolio of steerable devices enabling minimally invasive delivery of diagnostic and therapeutic tools for solid-organ cancers, closed an $8m Series A financing.
The round was led by Ajax Health with participation from Aperture Venture Partners and Western Technology Investment. In addition to capital, Ajax Health brings multiple executives to the Verix Health management team, including Duke Rohlen as Executive Chairman, Doug Koo as CFO and Joe Koblish as CTO.
The capital will fund ongoing R&D activities and prepare the product line for commercialization.
Led by Sasha Schrode, CEO, Verix Health is developing a suite of actively steerable surgical devices enabling minimally invasive diagnosis and treatment of lesions in difficult-to-access anatomies.
The company was founded by Professor Mark Yim, PhD and PCI Ventures at the University of Pennsylvania and incubated at the Pennovation Center in Philadelphia.